BridgeBio Pharma Cash from Financing (TTM) Insights

BridgeBio Pharma Inc (BBIO)

28.10 +0.26 (+0.95%) USD | NASDAQ | May 06, 16:00

28.10 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
March 31, 2024	580.83M
December 31, 2023	451.54M
September 30, 2023	462.44M
June 30, 2023	156.84M
March 31, 2023	137.28M
December 31, 2022	-13.13M
September 30, 2022	305.87M
June 30, 2022	168.97M
March 31, 2022	188.37M
December 31, 2021	736.45M
September 30, 2021	415.60M

Date	Value
June 30, 2021	553.83M
March 31, 2021	555.93M
December 31, 2020	447.19M
September 30, 2020	485.56M
June 30, 2020	850.29M
March 31, 2020	839.62M
December 31, 2019	398.79M
September 30, 2019	630.06M
June 30, 2019	260.83M
March 31, 2019	484.20M
December 31, 2018	501.55M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-13.13M

Minimum

Dec 2022

850.29M

Maximum

Jun 2020

430.66M

Average

449.36M

Median

Cash from Financing (TTM) Benchmarks